WallStSmart

PACCAR Inc (PCAR)vsSBC Medical Group Holdings Incorporated (SBC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PACCAR Inc generates 15779% more annual revenue ($27.82B vs $175.17M). SBC leads profitability with a 28.0% profit margin vs 9.0%. PCAR appears more attractively valued with a PEG of 1.00. SBC earns a higher WallStSmart Score of 72/100 (B).

PCAR

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 6.0Value: 5.3Quality: 7.0
Piotroski: 2/9Altman Z: 2.57

SBC

Strong Buy

72

out of 100

Grade: B

Growth: 6.0Profit: 9.0Value: 6.3Quality: 8.5
Piotroski: 2/9Altman Z: 3.94
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PCARSignificantly Overvalued (-43.2%)

Margin of Safety

-43.2%

Fair Value

$85.69

Current Price

$122.86

$37.17 premium

UndervaluedFair: $85.69Overvalued

Intrinsic value data unavailable for SBC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PCAR2 strengths · Avg: 8.5/10
Market CapQuality
$64.60B9/10

Large-cap with strong market position

PEG RatioValuation
1.008/10

Growing faster than its price suggests

SBC6 strengths · Avg: 9.7/10
P/E RatioValuation
8.6x10/10

Attractively priced relative to earnings

Operating MarginProfitability
38.6%10/10

Strong operational efficiency at 38.6%

EPS GrowthGrowth
338.9%10/10

Earnings expanding 338.9% YoY

Altman Z-ScoreHealth
3.9410/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
28.0%9/10

Keeps 28 of every $100 in revenue as profit

Debt/EquityHealth
0.189/10

Conservative balance sheet, low leverage

Areas to Watch

PCAR4 concerns · Avg: 3.8/10
P/E RatioValuation
25.8x4/10

Moderate valuation

Revenue GrowthGrowth
0.5%4/10

0.5% revenue growth

EPS GrowthGrowth
4.2%4/10

4.2% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

SBC3 concerns · Avg: 3.3/10
PEG RatioValuation
1.644/10

Expensive relative to growth rate

Market CapQuality
$423.73M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : PCAR

The strongest argument for PCAR centers on Market Cap, PEG Ratio. PEG of 1.00 suggests the stock is reasonably priced for its growth.

Bull Case : SBC

The strongest argument for SBC centers on P/E Ratio, Operating Margin, EPS Growth. Profitability is solid with margins at 28.0% and operating margin at 38.6%. Revenue growth of 13.4% demonstrates continued momentum.

Bear Case : PCAR

The primary concerns for PCAR are P/E Ratio, Revenue Growth, EPS Growth.

Bear Case : SBC

The primary concerns for SBC are PEG Ratio, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

PCAR profiles as a value stock while SBC is a mature play — different risk/reward profiles.

PCAR carries more volatility with a beta of 0.97 — expect wider price swings.

SBC is growing revenue faster at 13.4% — sustainability is the question.

PCAR generates stronger free cash flow (309M), providing more financial flexibility.

Bottom Line

SBC scores higher overall (72/100 vs 54/100), backed by strong 28.0% margins and 13.4% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

PACCAR Inc

INDUSTRIALS · FARM & HEAVY CONSTRUCTION MACHINERY · USA

PACCAR Inc is an American Fortune 500 company and counts among the largest manufacturers of medium- and heavy-duty trucks in the world. PACCAR is engaged in the design, manufacture and customer support of light-, medium- and heavy-duty trucks under the Kenworth, Peterbilt, Leyland Trucks, and DAF nameplates. PACCAR also designs and manufactures powertrains, provides financial services and information technology, and distributes truck parts related to its principal business.

SBC Medical Group Holdings Incorporated

INDUSTRIALS · CONSULTING SERVICES · USA

SBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.

Visit Website →

Want to dig deeper into these stocks?